Healthcare

Syngene International Ltd

SYNGENE · NSE · INE398R01022
₹359.9-1.89%consolidatedstandalone
Monday, 26 Oct 202611:31 am
Sentiment18 · Extreme Fear
Extreme FearFearNeutralGreedExtreme Greed
Market Cap₹14,465 Cr
P/E65.6
P/B3.0
EPS₹5.49
Div Yield0.4%
ROE6.6%
ROCE7.5%
ROE6.6%
1Y Return-43.07%
Avg. Volume0.8M

Price Chart

6645875114353583.0Cr5.9CrOct 2025Nov 2025Dec 2025Feb 2026Mar 2026Apr 2026May 2026Jul 2026

52-Week Range

₹344.45₹359.9₹678.95
52W Low52W High

About

Syngene International Ltd is a Healthcare company listed on NSE.

Healthcare

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap₹14,465 Cr
Current Price₹359.9
52W High / Low₹678.95 / ₹344.45
Stock P/E65.6
Price to Book3.0
EPS (TTM)₹5.49
Dividend Yield0.4%
ROE6.6%
1Y Return-43.07%
Day Change-1.89%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18
Sales₹3,600 Cr₹3,739 Cr₹3,642 Cr
Expenses₹2,797 Cr₹2,817 Cr₹2,598 Cr
Operating Profit₹803 Cr₹921 Cr₹1,045 Cr
OPM %22.0%25.0%29.0%
Other Income₹-12 Cr₹-9 Cr₹101 Cr
Depreciation₹454 Cr₹453 Cr₹433 Cr
Interest₹47 Cr₹49 Cr₹53 Cr
Profit Before Tax₹290 Cr₹411 Cr₹660 Cr
Tax₹69 Cr₹94 Cr₹164 Cr
Net Profit₹221 Cr₹317 Cr₹496 Cr
EPS (₹)5.57.912.3
Dividend Payout %—16%10%
Financial history locked

Register free to see 7 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹736 Cr₹1,037 Cr₹917 Cr₹911 Cr
Expenses₹645 Cr₹733 Cr₹708 Cr₹711 Cr
Operating Profit₹91 Cr₹303 Cr₹209 Cr₹200 Cr
OPM %12.3%29.3%22.8%21.9%
Depreciation₹112 Cr₹112 Cr₹114 Cr₹117 Cr
Interest₹10 Cr₹12 Cr₹12 Cr₹13 Cr
Net Profit₹-9 Cr₹148 Cr₹15 Cr₹67 Cr
EPS (₹)-0.23.70.41.7
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18
Liabilities
Equity Capital₹403 Cr₹402 Cr₹402 Cr
Reserves₹4,436 Cr₹4,324 Cr₹3,856 Cr
Borrowings₹458 Cr₹578 Cr₹555 Cr
Other Liabilities₹1,758 Cr₹1,492 Cr₹1,339 Cr
Total Liabilities₹7,055 Cr₹6,796 Cr₹6,152 Cr
Assets
Fixed Assets₹3,000 Cr₹2,802 Cr₹2,850 Cr
Investments₹741 Cr₹647 Cr₹548 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹2,268 Cr₹2,081 Cr₹1,916 Cr
Total Assets₹7,055 Cr₹6,796 Cr₹6,152 Cr
Balance sheet history locked

Register free to see 7 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹915 Cr₹-839 Cr₹-215 Cr₹-138 Cr
FY25₹1,168 Cr₹-744 Cr₹-142 Cr₹281 Cr
FY24₹1,042 Cr₹-494 Cr₹-551 Cr₹-4 Cr
FY23
FY22
FY21
FY20
FY19
FY18
Cash flow history locked

Register free to see 7 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
Dr. Agarwals Health Care Ltd₹15,064 Cr102.2+8.63%+0.18%
Choksi Asia Ltd——+13.5%+90.56%
Choksi Laboratories Ltd₹149 Cr68.8+7.97%+79.98%
Centenial Surgical Suture Ltd₹33 Cr—-7.42%-8.63%
Deep Health AI India Ltd——+3.07%-64.61%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-24Intimation Of Cancellation Of Meeting With Analyst/Institutional InvestorsBSE Filing2026-07-01Siddharth Mittal Appointed as Managing Director & CEO of Syngene InternationalPR Newswire

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.